Glioblastoma
Conditions
Interventions
Observation group:None
Sponsors
Tangdu Hospital,Fourth Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Age 18–65 years, regardless of gender; 2. Diagnosed with glioblastoma by clinical and radiological methods; 3. Patients with glioblastoma planned for craniotomy and resection; 4. Patients comply with the conventional postoperative treatment plan for gliomas; 5. Patients voluntarily participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Underwent preoperative radiochemotherapy; 2.Have severe cardiovascular or circulatory system diseases and are unable to tolerate surgery; 3.Participated in other investigational drug or device clinical trials within the past month; 4.Unable to understand the requirements of the trial or unable to complete the study follow-up plan; 5.Pregnant or breastfeeding women; 6.Patients who cannot complete the follow-up due to mental illness, cognitive disorders, or emotional disorders; 7.Subjects who are deemed unsuitable for participation in the study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluate the proportion of successful organoid models established from blood and tissue samples.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation the consistency of drug sensitivity between blood and tumor tissue organoids; | — |
Countries
China
Contacts
Public ContactLiang Wang
Tangdu Hospital,Fourth Military Medical University
Outcome results
None listed